For individuals facing Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a debilitating condition, the arrival of this treatment and Tafamidis meglumine represents a true advancement . These novel therapies stabilize the transthyretin protein, slowing its harmful build-up and alleviating the burden of the condition . Patients are now seeing positi… Read More